Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Endor Nanotechnologies is a Spanish biotechnology company specializing in the design and development of advanced medical products based on inorganic nanotechnology. The company utilizes a proprietary platform to create metallic nanoparticles that act as drug delivery systems or therapeutic agents by modulating biological pathways, particularly in oncology and dermatology. Their lead programs focus on treating complex conditions such as diabetic foot ulcers and various solid tumors through targeted nanomedicine. Endor operates with a dual business model, developing its own clinical pipeline while also providing nanotechnology solutions for the dermo-cosmetic industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Endor Nanotechnology.